PHRX logo

Pharmadrug Inc. Stock Price

CNSX:PHRX Community·CA$1.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PHRX Share Price Performance

CA$0.02
0.00 (0.00%)
CA$0.02
0.00 (0.00%)
Price CA$0.02

PHRX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Medium-low risk with weak fundamentals.

6 Risks
0 Rewards

Pharmadrug Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$337.9k

Other Expenses

-CA$337.9k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0031
0%
0%
-100.8%
View Full Analysis

About PHRX

Founded
2011
Employees
n/a
CEO
n/a
WebsiteView website
www.pharmadrug.ca

Pharmadrug Inc. operates as a specialty pharmaceutical company. The company focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. It also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs for potential commercialization and distribution; development of cepharanthine, a drug for the treatment of infectious disease and rare cancers; and research and development activities in the psychedelics space for the treatment of non-neuropsychiatric conditions. It has a license agreement with Southwest Research Institute. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug Inc. was incorporated in 2011 and is based in Toronto, Canada.

Recent PHRX News & Updates

Recent updates

No updates